The basic experimental model tested the ability of an infusion of human plasma to expand the normal plasma volume to a hypervolemic state and to maintain this expansion for several hours. The kinetics ...
A common first-line treatment for supporting cardiovascular function in preterm infants is volume expansion using saline, but this does not improve outcomes. This study aimed to determine if volume ...
On July 7, 2021, the U.S. Food and Drug Administration (FDA) issued new warnings regarding hydroxyethyl starch (HES) blood volume expanders. Specifically, the FDA is now requiring manufacturers to ...
Hydroxyethyl starch (HES) products should not be used to treat hypovolemia unless these synthetic colloids are absolutely necessary, warned FDA in a safety communication. The agency is requiring the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results